Antex Biologics (ANTX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX)

ANTX 1.090

+0.9%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Amigo Mike who wrote (617)	12/16/1997 7:58:00 AM
From: Ted Downs	Read Replies (1) of 1476

Michael, I agree with you that SKB would not buy shares in the open market probably ever with a small start-up such as this. There are other cheaper easier ways to acquire. Now as far as the options go I don't think that expiration of a deadline for additional investment ( in stock) can be viewed necessarily as a negative event. A small biotech such as antx would be very willing to amend any such expired agreement at this stage. The only risk SKB takes by not exercising an option is that a positive development in the antx lab could cost them more money for the shares wanted. So, I don't think that you can read anything extremely negative by the option being passed on at this point in time. The important part of the SKB agreement (the funding) is all they need right now.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next